Triple negative breast cancer (TNBC), a collective term for invasive breast cancers that lack expression of estrogen receptor, progesterone receptor and HER2, is responsible for 15–20% of breast cancers and it accounts for a disproportionate number of breast cancer deaths. The gene discussed is ERBB2; the disease is breast carcinoma.